APA (7th ed.) Citation

M, V., J, B., E, I., R, S., A, A., S, L., . . . J, M. (2024). Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis. Diabetes spectrum : a publication of the American Diabetes Association, 37(2), 165. https://doi.org/10.2337/ds23-0040

Chicago Style (17th ed.) Citation

M, Verdone, Bauman J, Iversen E, Schulman-Rosenbaum R, Antonacci A, Leffe S, Simpson J, Harris YT, and Marino J. "Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis." Diabetes Spectrum : A Publication of the American Diabetes Association 37, no. 2 (2024): 165. https://doi.org/10.2337/ds23-0040.

MLA (9th ed.) Citation

M, Verdone, et al. "Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis." Diabetes Spectrum : A Publication of the American Diabetes Association, vol. 37, no. 2, 2024, p. 165, https://doi.org/10.2337/ds23-0040.